Document is current
Any future updates will be listed below
-
Authors
Dar, Salman Ul Hassan https://orcid.org/0000-0002-7603-4245
Seyfarth, Marvin
Ayx, Isabelle https://orcid.org/0000-0003-3507-9006
Papavassiliu, Theano
Schoenberg, Stefan O.
Siepmann, Robert Malte
Laqua, Fabian Christopher
Kahmann, Jannik
Frey, Norbert
Baeßler, Bettina https://orcid.org/0000-0002-3244-3864
Foersch, Sebastian https://orcid.org/0000-0002-4740-6900
Truhn, Daniel https://orcid.org/0000-0002-9605-0728
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
Engelhardt, Sandy
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 25 June 2025
First Online: 11 August 2025
Competing interests
: S.O.S. is the director of the Department of Radiology and Nuclear Medicine at the University Medical Center in Mannheim, which has research agreements with Siemens Healthineers. B.B. is the founder and CEO of LernRad GmbH and a speaker at Bureau Bayer Vital GmbH. S.F. has received honoraria by MSD and BMS. D.T. holds shares in StratifAI GmbH and has received honoraria for lectures from Bayer. J.N.K. declares consulting services for Bioptimus, France; Panakeia, UK; AstraZeneca, UK; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI, Germany, Synagen, Germany, and Ignition Lab, Germany; has received an institutional research grant by GSK; and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, BMS, Roche, Pfizer and Fresenius. S.E. has received honoraria by Boehringer Ingelheim. The remaining authors declare no competing interests.
